0001555280false00015552802021-03-232021-03-23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 23, 2021
| | |
| Zoetis Inc. |
| (Exact name of registrant as specified in its charter) |
| | | | | | | | | | | | | | |
| Delaware | | 001-35797 | | 46-0696167 |
| (State or other jurisdiction | | (Commission File | | (I.R.S. Employer |
| of incorporation) | | Number) | | Identification No.) |
| | | | | | | | | | | | | | |
10 Sylvan Way, | Parsippany, | New Jersey | | 07054 |
| (Address of principal executive offices) | | (Zip Code) |
(973) 822-7000
| | |
(Registrant's telephone number, including area code)
|
| | |
| Not Applicable |
| (Former Name or Former Address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | | ZTS | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 23, 2021, Mr. Juan Ramón Alaix informed Zoetis Inc. (the “Company” or “Zoetis”) of his decision to retire from the Company’s Board of Directors as of May 20, 2021, the date of the Company’s annual shareholders meeting. As noted in the Company’s October 3, 2019 press release regarding leadership transition matters, Zoetis is greatly appreciative of Mr. Alaix and his contributions and wishes him all the best. Mr. Alaix’s decision to depart from the Board is part of the CEO transition and reflects his confidence in the Company’s leadership and operations, and is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | |
| ZOETIS INC. |
| | |
| Dated: March 24, 2021 | By: | /s/ Heidi C. Chen |
| | Heidi C. Chen |
| | Executive Vice President, |
| | General Counsel and Corporate Secretary |